Empathy, affection and sociability enhancement
Empathy, affection, and sociability enhancement is defined as the experience of a mind state which is dominated by intense feelings of compassion, talkativeness, and happiness. The experience of this effect creates a wide range of subjective changes to a person's perception of their feelings towards other people and themselves. These are described and documented in the list below:
- Increased sociability and the feeling that communication comes easier and more naturally.
- Increased urge to communicate or express one's affectionate feelings towards others, even if they happen to be strangers.
- Increased feelings of empathy, love, and connection with others.
- Increased motivation to resolve social conflicts and improve interpersonal relationships.
- Decreased negative emotions and mental states such as stress, anxiety, and fear.
- Decreased insecurity, defensiveness, and fear of emotional injury or rejection from others.
- Decreased irritability, aggression, anger, and jealousy.
Empathy, affection, and sociability enhancement is often accompanied by other coinciding effects such as stimulation, personal bias suppression, motivation enhancement, and anxiety suppression. It is most commonly induced under the influence of moderate dosages of entactogenic compounds such as MDMA, 4-FA, and 2C-B. However, it can also subtly occur to a much lesser extent under the influence of GABAergic depressants, and certain stimulants.
Compounds within our psychoactive substance index which may cause this effect include:
Anecdotal reports which describe this effect within our experience index include:
- Experience: 105mg Ephenidine - An Intense Emotional Experience
- Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
- Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
- Experience:0.75g MDMA - Possibly some MDA through metabolisation?
- Experience:1000 Morning Glory seeds - Rediscovering the Self
- Experience:12 mg AMT - Nicely Surprised
- Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
- Experience:170mg 4-AcO-DMT - Recklessness rewarded
- Experience:25mg - A labyrinth of organs and a storybook walk
- Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
- Experience:300µg LSD - Togetherness and the Silent Dusk
- Experience:30mg (smoked) DMT - The Monolith
- Experience:30mg - Psychostimulant egodeath
- Experience:3g mimosa / 2g syrian rue - I was the Universe's prophet
- Experience:42 mg TMA-6: Pure Bliss
- Experience:4F-EPH (15mg) - Untitled
- Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
- Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
- Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
- Experience:A night with Ethylphenidate
- Experience:BK-2C-B - Various experiences
- Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
- Experience:Unknown dosage / 3 tabs - Ego death and a total break through in the snow
- Responsible use
- Subjective effects index
- Psychedelics - Subjective effects
- Dissociatives - Subjective effects
- Nichols, David E. (1986). "Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens". Journal of Psychoactive Drugs. 18 (4): 305–313. doi:10.1080/02791072.1986.10472362. ISSN 0279-1072.
- The Great Entactogen - Empathogen Debate (from the Newsletter of the Multidisciplinary Association for Psychedelic Studies, MAPS - Volume 4 Number 2 Summer 1993 - pp 47-49) | https://www.maps.org/news-letters/v04n2/04247eed.html
- Bedi, Gillinder; Hyman, David; de Wit, Harriet (2010). "Is Ecstasy an "Empathogen"? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others". Biological Psychiatry. 68 (12): 1134–1140. doi:10.1016/j.biopsych.2010.08.003. ISSN 0006-3223.
- Scahill, Lawrence; Anderson, George M. (2010). "Is Ecstasy an Empathogen?". Biological Psychiatry. 68 (12): 1082–1083. doi:10.1016/j.biopsych.2010.10.020. ISSN 0006-3223.
- MDMA effects (Erowid) | https://erowid.org/chemicals/mdma/mdma_effects.shtml
- 4-FA (The Drug Classroom) | https://thedrugclassroom.com/video/4-fluoroamphetamine-4-fa/
- 4-Fluoroamphetamine(4-FA) – Critical Review Report | http://www.who.int/medicines/access/controlled-substances/5.4_4-FA_CRev.pdf?ua=1
- 2C-B effects (Erowid) | https://erowid.org/chemicals/2cb/2cb_effects.shtml
- González, Débora; Torrens, Marta; Farré, Magí (2015). "Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions". BioMed Research International. 2015: 1–9. doi:10.1155/2015/643878. ISSN 2314-6133.
- Wardle, Margaret C.; Garner, Matthew J.; Munafò, Marcus R.; de Wit, Harriet (2012). "Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior". Psychopharmacology. 223 (2): 199–210. doi:10.1007/s00213-012-2708-y. ISSN 0033-3158.